Reproductive Health Science Ltd. completed a placement of 10,714,285 shares at 14 Australian cents apiece to investors.
The Australian biotechnology company received about A$1.5 million in proceeds, which will be used for marketing and business development.
Taylor Collison Ltd. acted as lead broker for the offering.
As of June 2, US$1 was equivalent to A$1.34.